Prenatal Testing & Newborn Screening Poised to Grow Over $10.63 Billion by 2022

Feb 11, 2016, 08:10 ET from Research and Markets

DUBLIN, Feb. 11, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/h4x4mk/global_prenatal) has announced the addition of the "Global Prenatal Testing and Newborn Screening Market 2016-2022" report to their offering.

The global prenatal and newborn genetic testing market has a high growth potential in future and will grow over $10.63 billion by the end of forecast period. With the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA, there has been a gradual rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests.

Factors such as legal approval of the prenatal testing and newborn screening in most of the states of the U.S. government investment & regulations, and healthcare policies of other developed and emerging countries are contributing to the overall market growth.

The report has been further classified into prenatal testing and newborn screening. Prenatal testing further segmented on the basis of techniques (diagnostic & screening) and nature of the test (invasive & non-invasive). Prenatal testing is dominating the market and growing at a CAGR of 27.98% from 2016 to 2022.

Diagnosis technologies are holding the maximum market share and are expected to grow at 26.54% CAGR from 2016 to 2022. The techniques can either be invasive and non-invasive. By studying the current trends, it can be said that non-invasive prenatal testing are gaining more traction from the patients. Lifestyle preferences such as smoking, drinking, obesity, increasing maternity age, and genetic disorders are some of the factors responsible for the growth of the market.

North America is the largest contributor in the overall revenue generation in prenatal and newborn care, followed by the European region, and is expected to grow at a CAGR of 23.36% from 2016 to 2022.

Companies Mentioned:

  • Illumina, Inc.
  • Laboratory Corporation Of America Holdings
  • Natus Medical Incorporated
  • Perkinelmer, Inc.
  • Quest Diagnostics Inc.

Key Topics Covered:

1. Report Overview

2. Executive Summary

3. Market Overview

4 Competitive Insights

5 Industry Analysis

6 Global Prenatal Testing Market

7 Global Newborn Screening Testing Market

8 Global Prenatal Testing & Newborn Screening Market By Geography

9 Global Prenatal Testing & Newborn Screening: Key Players

For more information visit http://www.researchandmarkets.com/research/h4x4mk/global_prenatal

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

 

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com